tiprankstipranks
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
US Market
KKPCF
Kaken Pharmaceutical Co
RESEARCH TOOLSreports
Want to see KKPCF full AI Analyst Report?

Kaken Pharmaceutical Co (KKPCF) Income Statement

4 Followers

Kaken Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Kaken Pharmaceutical Co's total revenue was ¥18.05B, a decrease of -4.36% from the same quarter last year. In Q4, Kaken Pharmaceutical Co's net income was ¥-5.23B. See Kaken Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 94.03B¥ 76.87B¥ 72.04B¥ 72.98B¥ 76.03B
Gross Profit
¥ 58.26B¥ 39.24B¥ 38.54B¥ 39.56B¥ 41.58B
Operating Expenses
¥ 37.23B¥ 40.14B¥ 29.03B¥ 31.55B¥ 24.51B
Depreciation and Amortization
¥ 2.55B¥ 3.33B¥ 2.75B¥ 2.57B¥ 2.48B
EBITDA
¥ 22.02B¥ 2.43B¥ 12.57B¥ 9.40B¥ 16.38B
Operating Income
¥ 21.04B¥ -899.00M¥ 9.51B¥ 8.00B¥ 17.06B
Other Income/Expenses
¥ -1.60B¥ 3.21B¥ 283.00M¥ -1.18B¥ -3.18B
Pretax Income
¥ 19.43B¥ 2.31B¥ 9.80B¥ 6.82B¥ 13.88B
Net Income
¥ 13.95B¥ 2.14B¥ 8.03B¥ 5.44B¥ 9.55B
Per Share Metrics
Basic EPS
¥ 365.42¥ 56.55¥ 212.66¥ 144.79¥ 251.44
Diluted EPS
¥ 365.42¥ 56.55¥ 212.66¥ 144.79¥ 251.44
Weighted Average Shares Outstanding
 38.16M 37.91M 37.74M 37.57M 37.98M
Weighted Average Shares Outstanding (Diluted)
 38.16M 37.91M 37.74M 37.57M 37.98M
Currency in JPY

Kaken Pharmaceutical Co Earnings and Revenue History